PepGen Inc., (PEPG): Price and Financial Metrics

PepGen Inc., (PEPG): $16.96

1.58 (+10.27%)

POWR Rating

Component Grades













Add PEPG to Watchlist
Sign Up

Industry: Biotech



in industry

PEPG Stock Price Chart Interactive Chart >

Price chart for PEPG

PEPG Price/Volume Stats

Current price $16.96 52-week high $17.81
Prev. close $15.38 52-week low $4.32
Day low $15.22 Volume 41,100
Day high $17.19 Avg. volume 56,154
50-day MA $15.00 Dividend yield N/A
200-day MA $0.00 Market Cap 400.80M

PepGen Inc., (PEPG) Company Bio

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

PEPG Latest News Stream

Event/Time News Detail
Loading, please wait...

PEPG Latest Social Stream

Loading social stream, please wait...

View Full PEPG Social Stream

Latest PEPG News From Around the Web

Below are the latest news stories about PEPGEN INC that investors may wish to consider to help them evaluate PEPG as an investment opportunity.

Here's Why Momentum in PepGen, Inc. (PEPG) Should Keep going

PepGen, Inc. (PEPG) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Yahoo | January 31, 2023

Companies Like PepGen (NASDAQ:PEPG) Are In A Position To Invest In Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Yahoo | January 16, 2023

Here's What Could Help PepGen, Inc. (PEPG) Maintain Its Recent Price Strength

PepGen, Inc. (PEPG) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Yahoo | January 13, 2023

PepGen (PEPG): Differentiated Exposure To Growing Muscular Dystrophy Treatment Market

There remains an unmet need for medical advancement in the treatment Duchenne Muscular Dystrophy. Read about the opportunity for investors here.

Seeking Alpha | December 23, 2022

Why This PepGen Analyst Is Bullish On The Biotech Stock

HC Wainwright initiated coverage of PepGen Inc (NASDAQ: PEPG ) with a Buy rating and $26 price target . PepGen is developing next-generation antisense oligonucleotide (ASO) therapeutics for neuromuscular and neurologic diseases. PepGen''s lead candidate is PGN-EDO51, a peptide-conjugated ASO targeting Exon 51, which has shown significant exon-skipping activity and dystrophin expression in cardiac … Full story available on

Benzinga | December 21, 2022

Read More 'PEPG' Stories Here

PEPG Price Returns

1-mo 12.62%
3-mo 53.21%
6-mo 51.43%
1-year N/A
3-year N/A
5-year N/A
YTD 26.85%
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.62 seconds.